- Published on 15 October 2015
The Danish hearing aid manufacturer GN ReSound and Australian cochlear implant company Cochlear Limited have announced their plans to expand their existing collaboration. This strategic alliance will look to ‘develop the world’s smartest bimodal hearing solutions’ a press release states.
The companies are no strangers to each other as they started collaborating on technology and product development in 2011. The result of this initial partnership work was the use of the 2.4 GHz wireless technology from GN ReSound in the Cochlear Nucleus® 6 and Baha® 5 implants ― the implantable hearing industry’s first bimodal solution using True Wireless™.
The two companies ― under their Smart Hearing Alliance umbrella ― are now looking to extend their collaboration in market reach and product offerings which will provide bimodal solutions connecting Baha® bone conduction implants, Nucleus® cochlear implants, wireless accessories, Beltone and GN ReSound Smart Hearing™ aids.
A joint company statement says, “This greatly expanded partnership makes incredible strides in bringing natural, effortless hearing to more consumers with the most severe types of hearing loss. We are thrilled to have the opportunity not only to strengthen our joint development, but also commercialise the smartest bimodal hearing solutions”. The Smart Hearing Alliance will be implemented by countries from early 2016.
GN ReSound CEO, Anders Hedegaard said, “GN ReSound is committed to advancing what is possible for people with hearing loss. This collaborative offering will help us change the lives of so many more people.”
Cochlear CEO, Chris Smith said, “This is a big step forward for our customers and professionals. The majority of cochlear implant recipients are bimodal users, so simplifying the management and improving the performance of their hearing solutions will be a huge benefit.”
New Apple Inc. tech products to be announced on June 3 will reflect the computer giant's increasing focus on healthcare, in particular hearing features aimed at the so-called Silver Tsunami generation of ageing consumers.
A change in Costa Rica's hearing aid purchasing model has triggered a dispute between speech-hearing therapists and state health administrators.
April figures released by the European Hearing Instrument Manufacturers Association (EHIMA) show that global adoption of hearing aids in 2018 grew faster than in either of the two preceding years.
Dr. Debara L. Tucci will take over in September this year as the next director of the National Institute on Deafness and Other Communication Disorders (NIDCD), in charge of its annual budget for the nation's hearing matters of around $459m.
The fast-arriving healthcare benefits from evolving artifical intelligence (AI) technology mean a flexible "tailored" regulatory framework must be put in place, says the US Food and Drug Administration (FDA), though the agency quickly drew criticism for lack of clarity.
An Indian Institute of Science (IISc) study has produced an economical prototype for a phone-based hearing aid complete with therapy, aimed at helping children with hearing loss.